Vascular Biogenics Prices IPO

Cooley advised the underwriters on Vascular Biogenics' initial public offering. Vascular Biogenics is an Israel-based clinical-stage biopharmaceutical company committed to the discovery, development and commercialization of first-in-class treatments for cancer and immune-inflammatory diseases. The company now trades on the Nasdaq Global Stock Market under the symbol "VBLT."

Deutsche Bank Securities acted as the sole book running manager for the offering. JMP Securities and Oppenheimer & Co. acted as co-managers for the offering.

Susan Philpot (tax).
Brent Siler Partner, Washington, DC
Darren DeStefano Partner, Reston
Natasha Leskovsek Partner, Washington, DC
Bonnie Weiss McLeod Partner, Washington, DC
Susan Cooper Philpot Retired Partner, San Francisco
Mark Ballantyne Associate, Reston
Fraser Brown Partner, Washington, DC
Sandhya Deo Associate, Washington, DC